Skip to content

Author

Xiao-Dong Feng

We have 6 of 35 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Cancer immunotherapy and mitochondrial metabolic reprogramming

Overall, this review not only elucidates the mechanisms by which mitochondrial metabolic reprogramming drives tumor immune evasion but also provides a theoretical basis for optimizing metabolism-targeted immunotherapy.

Wen-Lin Kang, Jin-Yu Shi, Xu-Ran Zhang et al. · 0 citations
Review Open access Oct 2026

Histone modifications in laryngeal squamous cell carcinoma: from epigenetic reprogramming to precision therapy

Laryngeal squamous cell carcinoma (LSCC) is a common malignancy of the head and neck, accounting for the vast majority of laryngeal cancers. Its development involves complex interactions between genetic and epigenetic alterations. Histone post-translational modifications, as a crucial regulatory layer linking intracell...

Ze-Xi Lv, Qiu-Ping Li, Xiao-Dong Feng · 0 citations
Sep 2026

Relationship of the co-occurrence of sarcopenia and metabolic syndrome with cognitive trajectory deterioration in middle-aged and older adults: A national cohort study with causal forest analysis.

BACKGROUND Cognitive impairment constitutes a major public health burden in the aging population. Sarcopenia and metabolic syndrome are both highly prevalent in middle-aged and older adults. However, the impact of their co-occurrence on long-term cognitive trajectories remains unclear. OBJECTIVE To investigate the as...

Yan Chen, Ke-Wen Ma, Zi-Jia Meng et al. · 0 citations
Sep 2026

Combined associations of triglyceride-glucose index and biochemical sarcopenia index with cardiometabolic multimorbidity in middle-aged and older Chinese adults.

The triglyceride-glucose index is a robust and independent predictor of incident cardiometabolic multimorbidity and shows a very small incremental improvement over the TyG index alone, though the clinical significance is uncertain and requires external validation.

Yan Chen, Jun Chen, Zi-Jia Meng et al. · 0 citations
Aug 2026

Integrated bulk and single-cell transcriptomic analyses identify senescence-related hub genes and microenvironmental remodeling in sarcopenia

PCK1, EGFR, and MAPKAPK3 are senescence-related candidate biomarkers in sarcopenia and may reflect distinct yet interconnected biological processes involving metabolic adaptation, stromal remodeling, immune microenvironment alteration, and myogenic dysregulation.

Yan Chen, Ke-Wen Ma, Tian Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.